Top compounds associated with response to LRRC31


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.05
mRNA Axitinib GDSC1000 pan-cancer AAC 0.073 0.05
mRNA foretinib GDSC1000 pan-cancer AAC -0.066 0.05
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.078 0.05
mRNA thalidomide CTRPv2 pan-cancer AAC -0.11 0.06
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.067 0.06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.06
mRNA PHA-793887 GDSC1000 pan-cancer AAC -0.056 0.06
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.072 0.06
mRNA EX-527 CTRPv2 pan-cancer AAC 0.075 0.06
Download CSV